These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12266)

  • 41. Impact of droplet evaporation rate on resulting in vitro performance parameters of pressurized metered dose inhalers.
    Sheth P; Grimes MR; Stein SW; Myrdal PB
    Int J Pharm; 2017 Aug; 528(1-2):360-371. PubMed ID: 28599855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time-of-flight aerodynamic particle size analyzers: their use and limitations for the evaluation of medical aerosols.
    Mitchell JP; Nagel MW
    J Aerosol Med; 1999; 12(4):217-40. PubMed ID: 10724637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?
    O'Callaghan C; Cant M; Robertson C
    Thorax; 1994 Oct; 49(10):961-4. PubMed ID: 7974311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).
    Rowland M; Cavecchi A; Thielmann F; Kulon J; Shur J; Price R
    Pharm Res; 2018 Nov; 36(1):15. PubMed ID: 30478630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing Aerosol Performance of a Dry Powder Carrier Formulation with Increasing Doses Using a Novel Inhaler.
    Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
    AAPS PharmSciTech; 2019 Jan; 20(3):94. PubMed ID: 30690674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.
    Ross DL; Schultz RK
    J Aerosol Med; 1996; 9(2):215-26. PubMed ID: 10163351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
    Chew NY; Chan HK
    J Aerosol Med; 2001; 14(4):495-501. PubMed ID: 11791690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
    Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metered-dose inhalers, I: Drug content and particle size distribution of beclomethasone dipropionate.
    LeBelle M; Pike RK; Graham SJ; Ormsby ED; Bogard HA
    J Pharm Biomed Anal; 1996 May; 14(7):793-800. PubMed ID: 8809703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of Active Pharmaceutical Ingredients on Aerosol Electrostatic Charges from Pressurized Metered Dose Inhalers.
    Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
    Pharm Res; 2015 Sep; 32(9):2928-36. PubMed ID: 25788449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Entry port selection for detecting particle size differences in metered dose inhaler formulations using cascade impaction.
    Naini V; Chaudhry S; Berry J; Sharpe S; Hart J; Sequeira J
    Drug Dev Ind Pharm; 2004 Jan; 30(1):75-82. PubMed ID: 15000432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler.
    Pu Y; Kline LC; Khawaja N; Van Liew M; Berry J
    Drug Dev Ind Pharm; 2015 May; 41(5):737-43. PubMed ID: 24641447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
    Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols.
    Vidgren P; Silvasti M; Vidgren M; Paronen P; Tukiainen H; Lehti H
    Pharmazie; 1991 Jan; 46(1):41-3. PubMed ID: 1857729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A model for predicting size distributions delivered from pMDIs with suspended drug.
    Stein SW; Sheth P; Myrdal PB
    Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
    Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
    Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Size distribution of chromate paint aerosol generated in a bench-scale spray booth.
    Sabty-Daily RA; Hinds WC; Froines JR
    Ann Occup Hyg; 2005 Jan; 49(1):33-45. PubMed ID: 15596421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Influence of Electrostatic Controls on MDI Size Distribution Measurements.
    Stein SW; Rasmussen J; Walls S; Schultz DW; Oakley C; Drake JB
    AAPS PharmSciTech; 2019 Apr; 20(5):170. PubMed ID: 31004248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffraction.
    Martin GP; MacRitchie HB; Marriott C; Zeng XM
    Pharm Res; 2006 Sep; 23(9):2210-9. PubMed ID: 16900410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.
    Haghi M; Traini D; Young P
    Pharm Res; 2014 Jul; 31(7):1779-87. PubMed ID: 24549816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.